Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$105,000.00

Modulating glutamate signaling in neural stem cells to enhance regeneration after spinal cord injury

EF 2020-21

Résumé
Spinal cord injury (SCI) is a devastating condition, with annual medical costs estimated to exceed $1.5 billion in Canada. This is in addition to indirect costs of lost earnings and the immense personal loss incurred by patients and their families. To date, there remains no effective treatment for SCI. Stem cell-based approaches have the potential to regenerate lost neurons and restore damaged neural circuits after SCI. However, three major barriers remain that limit the effective clinical translation of stem cell therapies to SCI patients: (1) poor stem cell survival, (2) minimal neuronal formation (3) a lack of functional integration of neural stem cells into the existing spinal circuitry. Overcoming these barriers is essential in order to effectively regenerate the injured spinal cord and improve functional recovery in patients. Recently, I demonstrated that glutamate (the main excitatory neurotransmitter in the central nervous system) increases the survival and proliferation of spinal cord-derived neural stem cells via the AMPA subtype of glutamate receptors. Moreover, I showed that positive AMPA receptor modulation promotes neural stem cell survival and neurogenesis in vitro. In the proposed series of projects, I will characterize the downstream mechanisms involved in glutamate-mediated signaling in human spinal cord neural stem cells. I will test the therapeutic potential of positively modulating AMPA receptors in promoting endogenous and transplanted neural stem cell survival, neuronal formation and functional integration along with motor recovery in a clinically relevant rodent model of SCI. My findings will uncover important mechanisms to better harness the regenerative potential of neural stem cells in order to enhance neurogenesis, restore damaged spinal circuitry and improve recovery after SCI. This work will be transformative in advancing the clinical translation of stem cell therapies to SCI patients.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
439380
Name
Hachem Laureen D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Modulating glutamate signaling in neural stem cells to enhance regeneration after spinal cord injury
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Ampa Receptor; Glutamate; Neural Regeneration; Neural Stem Cells; Plasticity; Spinal Cord Injury
Abstract
Spinal cord injury (SCI) is a devastating condition, with annual medical costs estimated to exceed $1.5 billion in Canada. This is in addition to indirect costs of lost earnings and the immense personal loss incurred by patients and their families. To date, there remains no effective treatment for SCI. Stem cell-based approaches have the potential to regenerate lost neurons and restore damaged neural circuits after SCI. However, three major barriers remain that limit the effective clinical translation of stem cell therapies to SCI patients: (1) poor stem cell survival, (2) minimal neuronal formation (3) a lack of functional integration of neural stem cells into the existing spinal circuitry. Overcoming these barriers is essential in order to effectively regenerate the injured spinal cord and improve functional recovery in patients. Recently, I demonstrated that glutamate (the main excitatory neurotransmitter in the central nervous system) increases the survival and proliferation of spinal cord-derived neural stem cells via the AMPA subtype of glutamate receptors. Moreover, I showed that positive AMPA receptor modulation promotes neural stem cell survival and neurogenesis in vitro. In the proposed series of projects, I will characterize the downstream mechanisms involved in glutamate-mediated signaling in human spinal cord neural stem cells. I will test the therapeutic potential of positively modulating AMPA receptors in promoting endogenous and transplanted neural stem cell survival, neuronal formation and functional integration along with motor recovery in a clinically relevant rodent model of SCI. My findings will uncover important mechanisms to better harness the regenerative potential of neural stem cells in order to enhance neurogenesis, restore damaged spinal circuitry and improve recovery after SCI. This work will be transformative in advancing the clinical translation of stem cell therapies to SCI patients.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hachem, Laureen D
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~